Partnering
Soligenix is interested in identifying new partnership and merger opportunities for its existing products as well as new in-licensing candidates in the areas of HSC transplant, supportive cancer care, gastrointestinal and biodefense. We can provide attractive compensation for any leads that result in new licenses at Soligenix or a new partnership for one of our existing products.
Please direct Business Development inquiries to:
Evan Myrianthopoulos, Senior Vice President and Chief Financial Officer
Soligenix, Inc.
29 Emmons Drive - Suite C-10
Princeton, NJ 08540
Phone: (609) 538-8200
Fax: (609) 452-6467
E-mail: emyrian@soligenix.com
For more information:
